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Objective: To evaluate the safety and short term outcomes of a new, truly minimally-
invasive, mesh-less and dissection-less anchoring system for pelvic floor apical repair.
Methods: A prospective study was conducted using the NeuGuide™ device system for 
pelvic floor apical repair. The primary effectiveness outcome was centro-apical pelvic 
floor prolapse by POP-Q after six months. The primary safety outcome was intra-oper-
ative, immediate (first 48 h) post-operative complications and adverse effects after six 
months. A standardized questionnaire (UDI-6) to assess quality of life at entry and during 
follow-up visits was used. Patients’ six months-follow-up and evaluation are reported.
Results: The mean age of the study population (n=10) was 63.8±12.0 years. All patients 
had a previous prolapse surgery. Five had a previous hysterectomy and two had stress 
urinary incontinence symptoms. During surgery six patients had a concurrent colporrha-
phy. There was no injury to the bladder, rectum, pudendal nerves, or major pelvic vessels 
and no febrile morbidity was recorded. At six months, no cases of centro-apical recur-
rence were noted. Patients were satisfied with the procedure and had favorable quality 
of life scores. Using the UDI-6 questionnaire an improvement, in all domains was seen. 
Moreover, although the sample size was small, the improvement in urge and overflow 
incontinence related domains were demonstrated to be statistically significant.
Conclusions: This new NeuGuide™ device allows rapid and safe introduction of a sus-
pending suture through the sacrospinous ligament and makes sacrospinous ligament 
fixation easy to perform, while avoiding dissection and mesh complications.
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InTRODucTIOn
Pelvic organ prolapse (POP) is a common 
problem in women and often requires surgical 
correction. In the USA, about 200,000 women un-
dergo surgery for prolapse correction every year 
(1). The lifetime risk of a woman to undergo a sur-
gical procedure for the correction of pelvic floor 
dysfunctions (PFD) is 11%. Among these women, 
there is a close to 30% risk of re-operation due to 
failure or prolapse of another compartment (2).
 Apical prolapse is defined as the descent 
of the apex of the vagina into the lower vagina, 
to or beyond the hymeneal ring. The apex can be 
either the uterus and cervix, cervix alone, or va-
ginal vault, depending upon whether the woman 
has undergone hysterectomy. The classification of 
prolapse according to the separate compartments 
is arbitrary, since the vagina is a continuum and 
prolapse of one compartment is often associated 
with prolapse of another (3).
 Loss of apical support is usually present in 
women with advanced and symptomatic prolap-
se that extends beyond the hymen. Women may 
present with symptoms of anterior, posterior, cen-
tral prolapse or any combination of these. Clinical 
manifestations include a bulge sensation or va-
ginal pressure, urinary, defecatory or sexual dys-
function (4). There is growing understanding that 
adequate vaginal apex support is essential for a 
durable surgical repair in women with advanced 
prolapse (5). Moreover, surgical correction of the 
anterior and posterior walls may fail unless the 
apex is adequately supported (6).
 There is a wide variety of surgical treat-
ments available for prolapse; this indicates that 
there is a lack of consensus as to the optimal sur-
gical approach (5, 7).
 Transvaginal sacrospinous ligament fixa-
tion (SSLF) was shown to have shorter operating 
time, less wound complications, quicker recovery 
to daily activities, and was cheaper than abdo-
minal sacrocolpopexy (8). Moreover, the vaginal 
approach facilitates the concomitant correction of 
other vaginal defects as well. Because of a high 
risk for ureteral injury, the sacrospinous ligament 
(SSL) is preferred over the uterosacral ligament 
as the fixation point (9). However, transvaginal 
anchoring or placement of the fixation sutures 
through a deep, narrow space to the SSL is te-
chnically challenging and potentially dangerous. 
Indeed, numerous surgical adjuncts for SSL an-
choring or suture placement have been introdu-
ced over the years with no device proven to be 
superior to others (10-16). These techniques all 
require deep vaginal dissection in order to gain 
safe access to the SSL. Many SSLF operations in-
volving mesh implants were criticized by the FDA 
as having increased risk for severe and frequent 
adverse effects (17).
 We have recently published our prelimi-
nary study demonstrating the biomechanical pro-
perties, feasibility and potential advantages of a 
new device - the NeuGuide™ (18). This new ancho-
ring device intends to provide a truly minimally 
invasive, dissection-less approach for SSLF. This 
device enables the surgeon to perform a pelvic 
centro-apical support operation with no mesh im-
plants, using just suturing materials. The aim of 
the current prospective pilot study is to evaluate 
the safety and short term outcomes of this new 
anchoring system for pelvic floor apical repair.
MATERIALs AnD METhODs
Study design
 A prospective study was conducted, follo-
wing IRB approval. Surgeries were carried out by 
two experienced and well-trained urologic surge-
ons. All surgeries were performed using the same 
surgical technique. The primary effectiveness ou-
tcome was centro-apical pelvic floor prolapse by 
measuring the POP-Q point C/D after 6 months. 
The primary safety outcome was intraoperative 
complications and adverse effects after 6 months. 
A standardized questionnaire to assess quality of 
life (QoL) at entry and during follow-up visits was 
used.
Study population
 A pilot of ten patients who presented with 
a diagnosis of POP-Q stage III centro-apical pel-
vic floor prolapse with significant symptoms were 
offered to enroll in the study. Informed consent 
was obtained after thorough information was pre-
sented. Inclusion criteria included: women aged 
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50-80 years, POP-Q stage III centro-apical pelvic 
floor prolapse, scheduled to undergo a POP sur-
gery and had agreed to undergo it using the Neu-
GuideTM device, and who were willing to return for 
follow-up evaluation and fill questionnaires as in-
dicated by the study protocol. Women with a diag-
nosis of reproductive tract anomalies, prior pel-
vic radiation therapy or any malignancy, women 
with a significant history of pelvic inflammatory 
disease, women with a known allergy to Nickel 
or Nitinol and women unable to complete written 
questionnaires were excluded from the study.
Data collection
 Follow up assessment was carried out 4-6 
weeks, three months and six months after sur-
gery. We present the cumulative data regarding 
adverse outcomes at six months due to the small 
number of participants in this pilot study and the 
few events that occurred in order to avoid repeti-
tion and confusion. The UDI-6 score was provided 
for all follow up visits (n=8/10, n=6/10, n=9/10, 
respectively). Outcome measures included ana-
tomical and functional cure rates, levels of post-
-operative pain and dyspareunia as well as intra 
and post-operative complication rates. Data was 
collected prospectively and included demographic 
features and validated PFD related quality of life 
(QoL) questionnaires (Urogenital Distress Inven-
tory - UDI-6). Modified POP-Q scores (Ba, Bp, C 
and D) were measured preoperatively and at each 
post-operative visit. Stage of prolapse was defi-
ned as the most prolapsed compartment. Success 
of the operation was defined as a composite of 
no central compartment bulge symptoms and no 
prolapse beyond the stage I (1 cm proximal to the 
hymenal ring).
Device description and surgical technique
 The NeuGuide™ is designed to enable cen-
tro-apical pelvic floor support for the uterine cer-
vix or vaginal vault without need of either vagi-
nal dissection or mesh implants in patients with a 
central compartment defect that need suspension. 
The NeuGuide™ device is comprised of two main 
elements: an anchor unit and a delivery system. 
The delivery system enables the guidance, inser-
tion and deployment of the anchor element. The 
device’s anchor unit is designed as a sharp needle 
point Nitinol harpoon enabling piercing through 
the vaginal layers and the ligament. The anchor is 
deployed and placed with the use of an applicator. 
The anchor incorporates a surgical suture at its 
distal end, which following its deployment ena-
bles fixation and the continuation of the surgical 
procedure as intended for the repair process. It has 
a thimble that is an accessory to the device and 
can be used as an introducer for better handling 
of the NeuGuide™.
 The anchor penetration diameter is 2.0 
mm. Once deployed (passed the SSL), the wings 
open to 4.0 mm. The work channel length is 120 m 
(this limits the anchor penetration depth beyond 
the ligament in order to avoid injury). The device 
shaft diameter is 2.5 mm and its length 285 mm. 
The suture length is 70 cm and the work chan-
nel is designed to fit all sizes (self-adjusting). The 
applicator includes two concentric hollow shafts. 
The outer shaft constrains the anchor wings from 
being deployed. Once the button is pressed, the in-
ner shaft pushes the anchor distally and allows the 
wings to deploy. The applicator is equipped with 
a safety latch that protects the button, to avoid 
undesired deployment.
 The steps of the surgical procedure are 
presented in Table-1.
statistical analysis
 All statistical analyses were performed 
using the Statistical Package for the Social Scien-
ces (SPSS, software version 22.0). Data on con-
tinuous variables with normal distribution were 
presented as mean±SD. Ordinal variables were 
presented as median and range, statistical analysis 
was completed using the Wilcoxon test. Categori-
cal data were shown in counts. Two-sided p-value 
of <0.05 was considered significant.
REsuLTs
 Baseline preoperative clinical characte-
ristics of the patients who underwent NeuGuide™ 
surgery are presented in Table-2. The mean age of 
the study population at the time of surgery was 
63.8±12.0 years. All patients had a previous POP 
surgery, five had a previous hysterectomy and 2 
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Table 1 - The steps of the neuGuide device surgical procedure.
1 The NeuGuide device is mounted on the right index finger, and introduced into the vaginal cavity
2 The right iscial spine and the SSL are palpated through the vaginal wall
3 The index finger is stabilized intimately to the mid SSL
4 The anchor is deployed, and adequate pull-out force is proven
5 A 1 cm longitudinal shallow and high mucosal incision is made at the posterior vaginal wall
6 The anchor's suture is mounted on a virgin needle
7 The suture is inserted backwards through the vaginal wall at its entering point, passed under 
the vaginal wall, then through the cervical istmus and out to the vaginal cavity again through the 
posterior colpotomy
8 The previous steps are repeated on the left side and the suture is tied appropriately
9 The small posterior vaginal incision is closed
ssL= Sacro-spinous ligament
Table 2 - Preoperative demographic and clinical characteristics 
of 10 patients who underwent neuGuide™ surgery.
Characteristics n = 10
Age 63.8±12.0
Body Mass Index 27.1±3.7
Parity 2 (1-3)
Health problems  6
SUI 2
Previous hysterectomy 5
Previous POP surgery 10
POP 10
Point C/D POPQ median (range) 3 (2-4)
Central compartment prolapse stage ≥ 3 10
Cystocele stage ≥ 2 9
Rectocele stage ≥ 2 7





Values are presented as mean±SD, median and range or number of women 
Mus = Midurethral sling; suI = Stress urinary incontinence; POP = Pelvic organ 
prolapse; POPQ = Pelvic organ prolapse quantification system.
had stress urinary incontinence (SUI) symptoms. 
All patients had at least stage II prolapse in at 
least two compartments. Preoperative point C/D 
POPQ showed a median (range) of 3 [2-4]. During 
surgery 6 patients had a concurrent colporrhaphy 
and no injury to the bladder, rectum, pudendal 
nerves, or major pelvic vessels were noted.
 Table-3 presents postoperative outcomes 
of patients who underwent NeuGuide™ surgery. 
No post-operative febrile morbidity was recorded. 
At the six months-follow-up, none of the patients 
had prolapse symptoms. Patients were found to 
be satisfied with the procedure with a median of 
9, and favorable QoL scores were recorded with a 
median of 8 (on a scale of 0=not at all to 10=very 
much) (Table-3). All patients had significantly 
improved anatomical results (median point C/D 
POPQ score 0).
 Using the UDI-6 standardized question-
naire, all domains showed an improvement in 
symptom related QoL. Moreover, improvement 
in urge and overflow incontinence related do-
mains was demonstrated to be statistically sig-
nificant (Table-4).
DIscussIOn
 In this pilot study, we report our first 
short-term results of apical prolapse correction 
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Table 3 – Postoperative outcomes of patients who underwent 
neuGuide™ surgery.
Characteristics n = 10
Point C/D POPQ -5 (-4/-7)
Hematoma formation 0
Abscess formation 0
Post-operative pelvic pain 0
Post-operative buttock pain 1
De Novo dyspareunia 0
De Novo SUI 0
De Novo urinary frequency 0
De Novo urge incontinence 1
Recurrent POP 0
Satisfaction 8 (9-7)
Quality of life 9 (9-7)
Values are presented as median and range or number of women.
suI = Stress urinary incontinence; POP = Pelvic organ prolapse; POPQ = Pelvic 
organ prolapse quantification system.
Table 4 – urogenital symptoms and Quality of life assessed with urogenital Distress Inventory (uDI-6) (n=10).
UDI-6 Pre-surgery
(N=10)






Six months after 
surgery
(N=9)
Frequent urination 70 56* 50* 60
Urine leakage related to urgency 33 29 27 26*
Urine leakage related to physical activity 33 29 22 26
Small amounts of urine leakage (drops) 33 17 17 20*
Difficulty emptying your bladder 50 29 39 26
Pain or discomfort in the lower abdomen/
genitalia
50 28 33 30
Values are presented as percentages.
*P value <0.05
using a novel device - NeuGuide™ - a new ancho-
ring device intended to provide a truly minimally 
invasive, dissection-less approach for SSLF. Our 
findings demonstrate that the primary effective-
ness outcome, centro-apical pelvic floor prolapse 
at six months-follow-up, was highly successful. 
With regard to the primary safety outcomes, no 
intraoperative complications were recorded and 
after six months low complication rates were no-
ted. None of the patients suffered from recurrent 
prolapse at the six months-follow-up. Satisfaction 
and QoL scores were high.
 There is a wide variety of surgical proce-
dures available for apical prolapse repair. This in-
dicates that there is a lack of consensus as to the 
optimal surgical approach (5, 7). For years, mesh 
augmentation was the most common technique 
for apical prolapse repair. Following the FDA no-
tification in 2011 (16), due to high occurrence of 
late complications with mesh as a foreign body, 
the current recommendation of the American Col-
lege of Obstetricians and Gynecologists and the 
American Urogynecologic Society is for a judi-
cious use of mesh implants that should be reser-
ved for high risk individuals and selected patients 
only (19, 20).
 POP is common and often requires sur-
gical correction. The final surgical decision must 
be individualized. If a vaginal approach is chosen 
and the patient is sexually active, then anatomic 
preservation of the vagina should be pursued (21). 
This has traditionally been accomplished with 
SSLF or other vaginal procedures such as ute-
rosacral ligament suspension (USLS). USLS may 
be easier to perform than SSLF, with less risk of 
hemorrhage or infection, but does carry a higher 
risk of ureteral injury especially in patients with 
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concomitant anterior colporrhaphy (22). Moreo-
ver, USLS is less practical in treating patients with 
post-hysterectomy vault prolapse. In our study, 
five patients were post hysterectomy and six had a 
concomitant anterior or posterior prolapse repair.
 Informed decision-making about optimal 
surgical repair of apical prolapse with vaginal 
native tissue versus transvaginal mesh requires 
understanding the balance between the potential 
“harm” of mesh-related complications and the po-
tential “benefit” of reducing prolapse recurrence. 
Dieter et al. (23) examined this harm/benefit ba-
lance and concluded that based on the best avai-
lable evidence, there is considerable uncertainty 
about the harm/benefit trade-off between native 
tissue and transvaginal mesh for apical prolapse 
repair (23). In our study using the NeuGuide™ de-
vice, mesh complications were taken out of the 
equation.
 Recurrent prolapse is also a major concern 
following POP surgery. In our study, at six mon-
ths, all patients had significantly improved anato-
mical results (median point C/D POPQ score 0) and 
no cases of recurrence were noted. Lavelle et al. 
(24) reported their experience with POP recurren-
ce after native tissue anterior vaginal suspension 
procedures. After a mean follow-up at 5.8±3.7 
years, they reported prolapse recurrence rates of 
approximately 45% (isolated anterior 7.4%, isola-
ted apical 10.7%, isolated posterior 8.3%, multiple 
compartments 19%) (24). Compared to their re-
sults, ours seem promising. However, a long-term 
follow-up will be needed in order to establish the 
sustainability of these results.
 The primary limitations of the study inclu-
de its single-arm evaluation. The lack of a control 
group restricts the external validity of this stu-
dy. The 6-months evaluation period also may not 
be long enough to draw substantial conclusions. 
Another limitation that could restrict the external 
validity of this study was the fact that all surgi-
cal procedures were performed by two surgeons 
(MN and AT) who have extensive experience with 
pelvic surgery. However, since this is a new pro-
cedure it is unlikely that the surgeon’s experien-
ce has affected the results. Finally, our study was 
too small to add meaningful data to the literature 
about objective and subjective outcomes of this 
device but it was a pilot study on human subjects 
and the outcomes are encouraging.
 The strengths of the study include the 
prospective design allowing comprehensive data 
collection, the evaluation of self-reported patients 
centered outcomes and the use of validated QoL 
questionnaires. In addition, safety and efficacy of 
this new device were previously shown in a cada-
ver and animal study that was methodologically 
meticulous (18).
 In conclusion, this new NeuGuide™ device 
allows rapid and safe introduction of a suspen-
ding suture through the SSL and makes SSLF easy 
to perform, while avoiding dissection and mesh 
complications. This procedure might be appro-
priate for patients with loss of apical support or 
elongated coli who wish to avoid mesh augmenta-
tion. Further studies are needed in order to subs-
tantiate these results and to increase the external 
validity of our findings.
cOnfLIcT Of InTEREsT
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